CytoSorbents Corp. (CTSO)

9.90
0.32 3.34
NASDAQ : Health Technology
Prev Close 9.58
Open 9.50
Day Low/High 9.49 / 9.98
52 Wk Low/High 5.80 / 14.95
Volume 156.46K
Avg Volume 218.20K
Exchange NASDAQ
Shares Outstanding 31.65M
Market Cap 303.23M
EPS -0.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

CytoSorbents Reports Third Quarter 2018 Financial Results

CytoSorbents Reports Third Quarter 2018 Financial Results

Achieved record $19.1M in trailing 12-month product sales, up 63% from a year ago

Cytosorbents CEO on How to Avoid the Flu and 'Cytokine Storms'

Cytosorbents CEO on How to Avoid the Flu and 'Cytokine Storms'

Last year 80,000 people died from the flu - making it the most dangerous season in more than four decades.

CTSO Crosses Above Key Moving Average Level

CTSO Crosses Above Key Moving Average Level

In trading on Wednesday, shares of Cytosorbents Corp crossed above their 200 day moving average of $10.12, changing hands as high as $10.16 per share. Cytosorbents Corp shares are currently trading up about 6% on the day.

CytoSorbents To Report Q3 2018 Operating And Financial Results

CytoSorbents To Report Q3 2018 Operating And Financial Results

MONMOUTH JUNCTION, N.J.

CytoSorb® Assigned Dedicated Procedure Code In Switzerland

CytoSorb® Assigned Dedicated Procedure Code In Switzerland

MONMOUTH JUNCTION, N.J.

CytoSorbents REFRESH 2-AKI Protocol Amendment Approved By FDA

CytoSorbents REFRESH 2-AKI Protocol Amendment Approved By FDA

MONMOUTH JUNCTION, N.J.

CytoSorbents Achieves Record Total Revenue And CytoSorb Sales In The Second Quarter 2018

CytoSorbents Achieves Record Total Revenue And CytoSorb Sales In The Second Quarter 2018

Quarterly CytoSorb Sales Reach $5.2 Million, With Trailing 12-month CytoSorb Sales of $17.4 Million

CytoSorbents To Report Q2 2018 Operating And Financial Results

CytoSorbents To Report Q2 2018 Operating And Financial Results

MONMOUTH JUNCTION, N.J.

Aferetica And CytoSorbents Debut The PerLife™ System For Organ Preservation And Rehabilitation At The 27th International Congress Of The Transplantation Society

Aferetica And CytoSorbents Debut The PerLife™ System For Organ Preservation And Rehabilitation At The 27th International Congress Of The Transplantation Society

PerLife™ Is the First System Integrating a Sorbent Purification Technology to Perfuse, Cleanse, Recondition, and Preserve Harvested Solid Organs for Transplantation

General Electric's Stock Is Attractive for the First Time in 2 Years: Jim Cramer

General Electric's Stock Is Attractive for the First Time in 2 Years: Jim Cramer

Jim Cramer says earnings could break the tie between the bulls and the bears -- unless China blinks. Here's the game plan for next week.

CytoSorbents Added To The Russell 2000 And Russell 3000 Indexes

CytoSorbents Added To The Russell 2000 And Russell 3000 Indexes

MONMOUTH JUNCTION, N.J.

Interesting CTSO Put And Call Options For February 2019

Interesting CTSO Put And Call Options For February 2019

Investors in Cytosorbents Corp saw new options begin trading this week, for the February 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

CytoSorbents Officially Opens New U.S. CytoSorb Manufacturing Facility

CytoSorbents Officially Opens New U.S. CytoSorb Manufacturing Facility

New facility quadruples production capacity and is expected to accelerate margin expansion and drive operating profitability

Cytosorbents Enters Oversold Territory (CTSO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Oversold Conditions For Cytosorbents

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Oversold Conditions For Cytosorbents (CTSO)

Oversold Conditions For Cytosorbents (CTSO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Immunotherapies Will Grow in 2016; Fighting Inflammation Is Key -- CytoSorbents CEO

Immunotherapies Will Grow in 2016; Fighting Inflammation Is Key -- CytoSorbents CEO

Immunotherapy was one of the hottest -- and most crowded -- areas within biotech in 2015. And 2016 looks promising.

Blood Therapy Device Will Win Big in 2016 Says CytoSorbents CEO

Blood Therapy Device Will Win Big in 2016 Says CytoSorbents CEO

Immunotherapy was one of the hottest – and most crowded - areas within biotech in 2015.

5 Breakout Stocks Under $10 Set to Soar

5 Breakout Stocks Under $10 Set to Soar

These under-$10 stocks look ready to break out and trade higher from current levels.

4 Stocks Rising on Unusual Volume to Trade for Breakouts

4 Stocks Rising on Unusual Volume to Trade for Breakouts

These stocks rising on unusual volume are within range of triggering breakout trades.

Relative Strength Alert For Cytosorbents

Relative Strength Alert For Cytosorbents

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.